Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New data indicate mechanism of action of Immunitin

March 23, 2004

Novel Itk inhibitors with potential in immune, inflammatory and allergic disorders

March 23, 2004

Boosting endogenous interferon for hepatitis C therapy

March 23, 2004

Novel lipoxin A4 analogue with enhanced antiinflammatory activity in vivo

March 22, 2004

CCR5 antagonists promising candidates against graft rejection

March 17, 2004

New antibody program in Centocor/MorphoSys collaboration

March 15, 2004

New anti-TACI receptor antibodies and their use reported by Genentech

March 11, 2004

SBIR grant supports development of GelVac intranasal vaccine delivery platform

March 10, 2004

Altastaph receives fast track designation

March 8, 2004

German approval for Gamunex

March 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...